Doctor profile · Federal record
Dr. Valerie Galante, CRNP
Adult Health Nurse Practitioner (CMS: Nurse Practitioner) · Wyomissing, PA
- NPI 1720511843
- Accepts Medicare
- MIPS 99.2 / 100 · 2023
- 10 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1200 Broadcasting RD, Suite 200
Wyomissing, PA 196103206
(610) 374-8133
fax (610) 375-1206
Credentials & registration
- NPI registered
- April 2017 — 9 yrs on file
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 363LA2200X — NUCC code
- State license (1)
- Pennsylvania #SP017269
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1720511843. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
38,424
Distinct HCPCS
10
Medicare allowed
$784,715
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 21,360 | 230 | $23 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 13,650 | 13 | $10 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 931 | 168 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 322 | 228 | $106 | |
77080 |
Dxa bone density measurement of hip, pelvis, spine | 266 | 266 | $31 | |
96372 |
Injection of drug or substance under skin or into muscle | 260 | 193 | $12 | |
J3489 |
Injection, zoledronic acid, 1 mg | 235 | 47 | $9 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 228 | 179 | $58 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 226 | 198 | $74 | |
20611 |
Aspiration and/or injection of fluid large joint using ultrasound guidance | 166 | 84 | $102 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 1,330. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$2,819
Transactions
129
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 36 | $544.16 | |
| UCB, Inc. | 19 | $538.91 | |
| Amgen Inc. | 22 | $466.81 | |
| Janssen Biotech, Inc. | 14 | $233.45 | |
| AstraZeneca Pharmaceuticals LP | 9 | $175.46 | |
| ANI Pharmaceuticals, Inc. | 4 | $104.54 | |
| GlaxoSmithKline, LLC. | 5 | $104.26 | |
| Novartis Pharmaceuticals Corporation | 3 | $80.37 | |
| Genentech USA, Inc. | 3 | $67.24 | |
| Kyowa Kirin, Inc. | 2 | $58.60 | |
| Radius Health, Inc. | 2 | $53.02 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $52.33 | |
| Almatica Pharma LLC | 2 | $48.90 | |
| GENZYME CORPORATION | 2 | $47.17 | |
| PFIZER INC. | 3 | $45.30 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,039
Patients
292
Total drug cost
$109,147
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 184 | 52 | $1,732 |
| Alendronate Sodium | Generic | 178 | 63 | $2,156 |
| Duloxetine Hcl | Generic | 150 | 42 | $4,795 |
| Hydroxychloroquine Sulfate | Generic | 126 | 35 | $7,259 |
| Methotrexate (Methotrexate Sodium) | Brand | 123 | 43 | $6,415 |
| Gabapentin | Generic | 71 | 26 | $1,439 |
| Ibandronate Sodium | Generic | 41 | 15 | $2,128 |
| Tramadol Hcl | Generic | 32 | 16 | $201 |
| Pregabalin | Generic | 30 | 0 | $664 |
| Mycophenolate Mofetil | Generic | 27 | 0 | $4,106 |
Hospital affiliations
Frequently asked questions
What is Dr. Valerie Galante's medical specialty?
Dr. Valerie Galante practices Adult Health Nurse Practitioner in Wyomissing, PA.
Where does Dr. Valerie Galante practice?
Dr. Valerie Galante practices at 1200 Broadcasting RD, Wyomissing, PA 196103206. Office phone: 6103748133.
What is Dr. Valerie Galante's NPI?
Dr. Valerie Galante's National Provider Identifier (NPI) is 1720511843, issued by NPPES.
Does Dr. Valerie Galante accept Medicare assignment?
Yes. Dr. Valerie Galante accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Valerie Galante commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301). Source: CMS Medicare Physician & Other Practitioners file.